Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BMGL NASDAQ:BRTX NYSE:CCM NASDAQ:EUDA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBMGLBasel Medical Group$1.85+3.7%$2.09$0.91▼$9.40$34.04MN/A3.40 million shs119,751 shsBRTXBiorestorative Therapies$1.47-1.0%$1.55$1.21▼$2.55$11.69M-0.43194,053 shs17,704 shsCCMConcord Medical Services$5.94-1.7%$5.42$3.80▼$10.77$25.76M-1.0419,586 shs819 shsEUDAEUDA Health$1.44+16.1%$2.34$1.03▼$6.30$53.51M-0.1102,713 shs277,005 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBMGLBasel Medical Group-0.56%-10.10%-10.10%-20.54%+177,999,900.00%BRTXBiorestorative Therapies+2.07%-1.99%-3.27%-13.39%-22.92%CCMConcord Medical Services-1.43%+9.21%+8.71%+4.35%+4.89%EUDAEUDA Health+8.77%+16.98%-52.31%-66.84%-65.56%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBMGLBasel Medical Group$1.85+3.7%$2.09$0.91▼$9.40$34.04MN/A3.40 million shs119,751 shsBRTXBiorestorative Therapies$1.47-1.0%$1.55$1.21▼$2.55$11.69M-0.43194,053 shs17,704 shsCCMConcord Medical Services$5.94-1.7%$5.42$3.80▼$10.77$25.76M-1.0419,586 shs819 shsEUDAEUDA Health$1.44+16.1%$2.34$1.03▼$6.30$53.51M-0.1102,713 shs277,005 shsBeginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBMGLBasel Medical Group-0.56%-10.10%-10.10%-20.54%+177,999,900.00%BRTXBiorestorative Therapies+2.07%-1.99%-3.27%-13.39%-22.92%CCMConcord Medical Services-1.43%+9.21%+8.71%+4.35%+4.89%EUDAEUDA Health+8.77%+16.98%-52.31%-66.84%-65.56%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBMGLBasel Medical Group 0.00N/AN/AN/ABRTXBiorestorative Therapies 0.00N/AN/AN/ACCMConcord Medical Services 0.00N/AN/AN/AEUDAEUDA Health 4.00Strong BuyN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBMGLBasel Medical GroupN/AN/AN/AN/AN/AN/ABRTXBiorestorative Therapies$400K29.23N/AN/A$1.23 per share1.19CCMConcord Medical Services$52.60M0.49N/AN/A$51.05 per share0.12EUDAEUDA Health$4.01M13.34N/AN/A($0.07) per share-20.57Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBMGLBasel Medical GroupN/AN/A0.00∞N/AN/AN/AN/AN/ABRTXBiorestorative Therapies-$8.98M-$1.27N/AN/AN/A-1,772.40%-137.00%-88.31%11/11/2025 (Estimated)CCMConcord Medical Services-$42.23MN/A0.00∞N/AN/AN/AN/AN/AEUDAEUDA Health-$15.36MN/A0.00N/AN/AN/AN/AN/AN/ALatest BRTX, EUDA, BMGL, and CCM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/12/2025Q2 2025BRTXBiorestorative Therapies-$0.41-$0.30+$0.11-$0.30$0.34 million$0.30 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBMGLBasel Medical GroupN/AN/AN/AN/AN/ABRTXBiorestorative TherapiesN/AN/AN/AN/AN/ACCMConcord Medical ServicesN/AN/AN/AN/AN/AEUDAEUDA HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBMGLBasel Medical GroupN/AN/AN/ABRTXBiorestorative TherapiesN/A2.072.07CCMConcord Medical Services1.670.460.45EUDAEUDA HealthN/A0.180.15Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBMGLBasel Medical GroupN/ABRTXBiorestorative Therapies69.38%CCMConcord Medical ServicesN/AEUDAEUDA Health4.35%Insider OwnershipCompanyInsider OwnershipBMGLBasel Medical GroupN/ABRTXBiorestorative Therapies30.80%CCMConcord Medical Services46.50%EUDAEUDA HealthN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBMGLBasel Medical Group3618.45 millionN/AN/ABRTXBiorestorative Therapies77.98 million5.52 millionNot OptionableCCMConcord Medical Services9704.34 million2.32 millionNot OptionableEUDAEUDA Health237.16 millionN/ANot OptionableBRTX, EUDA, BMGL, and CCM HeadlinesRecent News About These CompaniesEUDA Health Holdings Adjusts Convertible Note Agreement with InvestorSeptember 22 at 7:31 AM | tipranks.comEUDA Health signs LOI to potentially acquire GO POSBSeptember 10, 2025 | msn.comEUDA Health Holdings Limited Signs Letter of Intent to Acquire GO POSB Organoids Pte Ltd for Strategic Expansion into iPSC SolutionsSeptember 10, 2025 | quiverquant.comQEUDA Signs Letter of Intent to Potentially Acquire GO POSBSeptember 10, 2025 | globenewswire.comEUDA Health Holdings Limited (NASDAQ:EUDA) Short Interest Up 218.6% in AugustSeptember 5, 2025 | marketbeat.comEUDA Health Expands into T-Cell Immunotherapy with New Malaysian PartnershipSeptember 4, 2025 | msn.comEUDA Health expands into T-cell immunotherapySeptember 4, 2025 | msn.comEUDA Strategically Expands into T-Cell Immunotherapy – Strengthening Its Stem Cell Therapy PortfolioSeptember 4, 2025 | markets.businessinsider.comEUDA Signs Letter of Intent to Potentially Acquire Chemokine Pte LtdAugust 28, 2025 | finance.yahoo.comHighly potent cannabis products tied to risk of psychosis, schizophrenia, and addiction, study findsAugust 27, 2025 | msn.comEUDA Expands Wellness Product Portfolio With A Next-Generation Immune Health SupplementAugust 26, 2025 | markets.businessinsider.comEUDA Health Secures Global Rights for New Immune SupplementAugust 26, 2025 | tipranks.comEUDA Health Holdings Secures $10 Million Convertible Note AgreementAugust 13, 2025 | theglobeandmail.comNew toolkit supports hepatitis prevention and care in European prisonsAugust 7, 2025 | msn.comEUDA Health Holdings Limited (NASDAQ:EUDA) stock most popular amongst retail investors who own 47%, while private companies hold 26%July 30, 2025 | finance.yahoo.comBRIEF-Euda Health Holdings Files For Offering Of Up To $10 Million Of Ordinary SharesJune 25, 2025 | sg.finance.yahoo.comEUDA Health Holdings Initiates $10 Million At The Market OfferingJune 24, 2025 | tipranks.comEUDA Health’s 47% decline validates InvestingPro’s overvalued warningJune 10, 2025 | investing.comMidwest Addiction Counsellor Warns “No Illicit Drug Is Absolutely Safe”June 9, 2025 | clare.fmCRising deaths, fake pills, gang violence: How the EU is struggling to cope with illegal drug problemJune 6, 2025 | msn.comReport: Synthetic Opioids, Cathinones Surge in EuropeJune 5, 2025 | occrp.orgONew MarketBeat Followers Over TimeMedia Sentiment Over TimeBRTX, EUDA, BMGL, and CCM Company DescriptionsBasel Medical Group NASDAQ:BMGL$1.84 +0.07 (+3.65%) As of 01:50 PM EasternBasel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.Biorestorative Therapies NASDAQ:BRTX$1.46 -0.02 (-1.01%) As of 02:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. The company was incorporated in 1997 and is based in Melville, New York.Concord Medical Services NYSE:CCM$5.94 -0.11 (-1.74%) As of 02:01 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.EUDA Health NASDAQ:EUDA$1.44 +0.20 (+16.13%) As of 02:03 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 High-Yields at 52-Week Lows: Buy, Sell, or Hold Advance Auto Parts is A Great Risk/Reward Play If EPS Delivers 3 Small Caps That Insiders Are Buying Amprius Technologies: Anatomy of a Textbook, Raging Bull Market Banks Boost Gold Forecasts: One Sees +30% Bull-Case Potential These 3 Stocks Boosting Buybacks Have Rallying Potential GameStop Partying Like It’s 2021: What’s Behind Its 2025 Rebound? Hims & Hers Stock Pushes to Highs on Healthcare Rate Cut Frenzy Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
